Diabetes Clinical Trials in San Antonio, Texas
32 recruitingSan Antonio, Texas
Showing 1–20 of 32 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 1
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
ObesityHealthyOverweight+1 more
Eli Lilly and Company216 enrolled6 locationsNCT06945419
Recruiting
Phase 4
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Type 2 DiabetesSpinal Cord Injuries
Marzieh Salehi50 enrolled2 locationsNCT06706284
Recruiting
Phase 2
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled107 locationsNCT06368817
Recruiting
Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Chronic Kidney DiseasesType 2 Diabetes Mellitus
Prokidney685 enrolled95 locationsNCT05099770
Recruiting
Phase 1
SGLT2i, Pioglitazone, and Ketone Production in T2D
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio64 enrolled1 locationNCT07053319
Recruiting
Phase 3
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Type 2 Diabetes (Adult Onset)
The University of Texas Health Science Center at San Antonio256 enrolled2 locationsNCT06246799
Recruiting
Phase 3
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Type 2 Diabetes (T2DM)LipidemiaMetabolic Syndrome (MetS)
NewAmsterdam Pharma300 enrolled20 locationsNCT07219602
Recruiting
Phase 1
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC64 enrolled11 locationsNCT07089784
Recruiting
Phase 2
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
ObesityWeight LossObese+1 more
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics50 enrolled17 locationsNCT07400588
Recruiting
Early Phase 1
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
Type 2 DiabetesHeart Failure, Reduced Ejection Fraction
The University of Texas Health Science Center at San Antonio10 enrolled1 locationNCT06108076
Recruiting
Phase 4
Quantifying Hepatic Mitochondrial Fluxes in Humans
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio60 enrolled2 locationsNCT05305287
Recruiting
Phase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
T2DM (Type 2 Diabetes Mellitus)
Ascletis Pharma (China) Co., Limited100 enrolled8 locationsNCT07321678
Recruiting
Phase 4
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Type 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection Fraction
The University of Texas Health Science Center at San Antonio78 enrolled1 locationNCT05838287
Recruiting
Not Applicable
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Diabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio700 enrolled1 locationNCT02969798
Recruiting
Not Applicable
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Diabetes Mellitus, Type 2DiabetesType 2 Diabetes+2 more
Endogenex, Inc.264 enrolled45 locationsNCT06267391
Recruiting
Phase 1
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio29 enrolled1 locationNCT07053306
Recruiting
Early Phase 1
SGLT2i, Hepatic Glucose Production, and SNS
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio22 enrolled1 locationNCT07053293
Recruiting
Phase 4
Dapagliflozin Plus Pioglitazone in T1DM
Type 1 Diabetes Mellitus
The University of Texas Health Science Center at San Antonio120 enrolled3 locationsNCT03878459
Recruiting
Phase 1
SGLTi, Hepatic Glucose Production and Ketogenesis
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio30 enrolled1 locationNCT05960656